Martini, Jean-francois Andre,Tarazi, Jamal Christo,Perini, Rodolfo Fleury,Mauro, David J.
申请号:
AU2015214390
公开号:
AU2015214390A1
申请日:
2015.02.03
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a VEGFR inhibitor, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-Ll.